Very few studies have followed patients with renal cell carcinoma for long enough to characterize late relapses. Newly published research suggests that late-recurring tumours are more likely to be of low nuclear grade and show a better response to first-line targeted therapy than early relapsing cancers
Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years ...
Purpose: Late recurrence of renal cell carcinoma is not a rare event. In this retrospective study we...
This thesis provides novel insights into the detection, recurrence patterns and management of metast...
BACKGROUND: A subset of primarily localized renal cell carcinoma (RCC) patients will experience dise...
OBJECTIVES: To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival ...
Renal cell carcinoma recurrences are rare in low-risk patients. Potentially curable recurrences are ...
Background: Late relapse with presentation of metastatic disease >5 years after nephrectomy with cur...
BACKGROUND: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell ...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
Renal cell carcinoma (RCC) is responsible for 4% of all neoplasms in adults and for 80% of all prima...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
OBJECTIVES: To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival ...
Background: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell ...
Purpose: Late recurrence of renal cell carcinoma is not a rare event. In this retrospective study we...
Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years ...
Purpose: Late recurrence of renal cell carcinoma is not a rare event. In this retrospective study we...
This thesis provides novel insights into the detection, recurrence patterns and management of metast...
BACKGROUND: A subset of primarily localized renal cell carcinoma (RCC) patients will experience dise...
OBJECTIVES: To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival ...
Renal cell carcinoma recurrences are rare in low-risk patients. Potentially curable recurrences are ...
Background: Late relapse with presentation of metastatic disease >5 years after nephrectomy with cur...
BACKGROUND: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell ...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
Renal cell carcinoma (RCC) is responsible for 4% of all neoplasms in adults and for 80% of all prima...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
OBJECTIVES: To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival ...
Background: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell ...
Purpose: Late recurrence of renal cell carcinoma is not a rare event. In this retrospective study we...
Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years ...
Purpose: Late recurrence of renal cell carcinoma is not a rare event. In this retrospective study we...
This thesis provides novel insights into the detection, recurrence patterns and management of metast...